PMV Pharmaceuticals (PMVP) Competitors

Vor Biopharma (NASDAQ:VOR) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Does the media favor VOR or PMVP?

In the previous week, Vor Biopharma had 1 more articles in the media than PMV Pharmaceuticals. MarketBeat recorded 1 mentions for Vor Biopharma and 0 mentions for PMV Pharmaceuticals. PMV Pharmaceuticals' average media sentiment score of 1.70 beat Vor Biopharma's score of 0.47 indicating that PMV Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Vor Biopharma	Neutral
PMV Pharmaceuticals	Very Positive

Which has more volatility and risk, VOR or PMVP?

Vor Biopharma has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500.

Which has preferable earnings and valuation, VOR or PMVP?

Vor Biopharma is trading at a lower price-to-earnings ratio than PMV Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vor Biopharma	N/A	N/A	N/A	-$1.51	-1.39
PMV Pharmaceuticals	N/A	N/A	-$58.71M	-$1.18	-1.19

Is VOR or PMVP more profitable?

Vor Biopharma's return on equity of 0.00% beat PMV Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vor Biopharma	N/A	N/A	N/A
PMV Pharmaceuticals	N/A	-32.54%	-29.59%

Do analysts prefer VOR or PMVP?

PMV Pharmaceuticals has a consensus price target of $5.50, suggesting a potential upside of 292.86%. Given PMV Pharmaceuticals' higher possible upside, analysts clearly believe PMV Pharmaceuticals is more favorable than Vor Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vor Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
PMV Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders hold more shares of VOR or PMVP?

97.3% of Vor Biopharma shares are held by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are held by institutional investors. 2.9% of Vor Biopharma shares are held by company insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Vor Biopharma beats PMV Pharmaceuticals on 7 of the 13 factors compared between the two stocks.